|Articles|November 1, 2013

Spectroscopy

  • Spectroscopy-11-01-2013
  • Volume 28
  • Issue 11

Market Profile: Secondary Ion Mass Spectrometry

Although mass spectrometers are more commonly associated with life science applications, there are some mass spectrometry (MS) techniques that are specifically designed for surface science applications.

Although mass spectrometers are more commonly associated with life science applications, there are some mass spectrometry (MS) techniques that are specifically designed for surface science applications. One of the most prominent such techniques is secondary ion mass spectrometry (SIMS). Like most surface science techniques involving electron or ion optics, SIMS is carried out under vacuum conditions. An ion beam is directed at a spot on the surface of the sample, sputtering atoms off of the sample surface. These secondary ions are introduced into the mass spectrometer for analysis. Several options are commercially available for the mass analyzer, including single-quadrupole, time-of-flight, and magnetic-sector instruments. The mass analyzer provides the elemental composition of the sample directly beneath the ion beam. To build up a two-dimensional image of the surface, the ion beam is rastered across the sample. The ion beam can also be used to sputter away the sample layer by layer, allowing depth profile analysis.

SIMS market demand by industry for 2012.

SIMS is commonly used to analyze semiconductor materials and other materials used in electronics, such as data storage media. The sensitivity to the surface layer allows SIMS to analyze thin films that are deposited on these materials. SIMS is also used in research laboratories in both academic and government settings. Although materials analysis applications are common here, there are also some environmental applications in the analysis of particulate matter making up air pollution. The total market demand for SIMS amounted to less than $100 million in 2012.

The foregoing data were adapted and extracted from SDi's market analysis and perspectives report entitled Mass Spectrometry: Limitless Innovation in Analytical Science, October 2013. For more information, visit www.strategic-directions.com.


Related to this article

Brandon E. Boor is the Dr. Margery E. Hoffman Associate Professor in the Lyles School of Civil and Construction Engineering at Purdue University. | Photo Credit: © Brandon Boor.
In the second part of our interview with Brandon Boor of Purdue University, he discusses how his team controls experimental variables during cleaning experiments in order to obtain interpretable data.
Scientist With Portable Spectrometer in Natural Field Setting ©  By Tika -chronicles-stock.adobe.com
The bulky bench-top NIR spectrometer is quietly being dismantled and rebuilt as a wafer-scale photonic chip, a self-calibrating algorithm, and a sensor small enough to ride in a shirt pocket. What once demanded a grating, a moving mirror, and a climate-controlled lab now fits inside a handheld module, a bioreactor probe, or a drone payload, and it increasingly figures out what it is looking at on its own.
Sizing Up the Nanoscale: Measuring Nanocluster Aerosol in Indoor Air
In the first part of a multi-part Q&A, Brandon Boor, the Dr. Margery E. Hoffman Associate Professor in the Lyles School of Civil and Construction Engineering at Purdue University, describes the instrumentation and methodology behind measuring nanoparticle size distributions at the nanocluster scale (1–3 nm) and outlines the technical challenges of acquiring reliable, real-time data at these dimensions.
Human body wireframe on glowing platform undergoing futuristic body scan. © sergray(noAIelemens) -chronicles-stock.adobe.com
Jurgen Popp, Thomas Mayerhofer, and colleagues at Leibniz IPHT and Friedrich Schiller University Jena introduce the Personalized Optical Digital Twin (PODT), a Photonics21 contribution to Europe's Virtual Human Twin ecosystem that connects molecular photonics—Raman blood analysis, coherent Raman tissue imaging, and multimodal endomicroscopy—with longitudinal physiology and clinical data. Drawing on the published multicenter INTELLIGENCE trials, the authors argue that technical feasibility and clinical utility must be evaluated separately as the field moves toward Europe's FP10 research agenda.